Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

3.72
Delayed Data
As of 10:01am ET
 -0.04 / -1.06%
Today’s Change
3.22
Today|||52-Week Range
7.95
-19.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.00799.0K35.4M
 
 
 
Depreciation And Amortization38.3K67.9K105.8K108.3K
 
 
 
 
 
 
Operating ExpensesGross Income-38.3K-67.9K----
 
 
 
General Expenses22.2M24.1M30.5M52.8M
 
 
 
 
 
Research And Development14.9M16.3M20.3M43.2M
 
 
 
 
 
Total Operating Expenses22.3M24.1M30.6M52.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.3M-24.1M-29.8M-17.6M
 
 
 
 
 
Interest Expense On Debt70.0K70.0K70.0K662.4K
 
 
 
 
 
Other Expenses-19.3K-15.8K29.9K-75.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.3M-24.1M-29.7M-17.4M
 
 
 
 
 
Net Income-22.3M-24.1M-29.7M-17.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.5M18.6M22.6M28.6M
 
 
 
 
 
Shares To Calculate EPS Diluted15.5M18.6M22.6M28.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.44-$1.30-$1.31-$0.61
 
 
 
 
 
EPS Diluted-$1.44-$1.30-$1.31-$0.61